Drug
Aav2haqp1
Aav2haqp1: highest development phase Phase 1, developed by MeiraGTx. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- MeiraGTx
Trials
| Drug | Phase | Indication |
|---|---|---|
| AAV2hAQP1 NCT02446249 | Phase 1 | Squamous Cell Head and Neck Cancer |
Latest
No recent events.
Follow Aav2haqp1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.